J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 5 (1969), 149-150; DOI 10.1099/0022-1317-5-1-149
© 1969 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Field, E. J.
Right arrow Articles by Keith, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Field, E. J.
Right arrow Articles by Keith, A.
Agricola
Right arrow Articles by Field, E. J.
Right arrow Articles by Keith, A.

Failure of Interferon to Modify Scrapie in the Mouse

E. J. Field, Greta Joyce and A. Keith

Medical Research Council Demyelinating Disease Unit Newcastle General Hospital, Westgate Road Newcastle upon Type 4

Because of the unusual properties of scrapie agent and doubt as to its being truly a virus, experiments were undertaken to find out if an interferon stimulating agent might influence the development or course of the disease following inoculation of infective material into mice. A group of 12 three-week-old male mice was inoculated intraperitoneally with 0.1 ml. of 5% Statolon made up in sterile 1% sodium bicarbonate solution one week before challenge with 0.1 ml. 10-1 scrapie mouse brain suspension injected intraperitoneally. A second Statolon injection was given the next day and at weekly intervals until the end of the experiment. At the same time six similar mice were inoculated intraperitoneally with the same scrapie material to serve as controls.

Experimental and control animals both developed clinical signs after 7 months, with no difference between the groups as to incubation period or the way in which signs evolved. All animals were examined histologically for confirmation of disease.

Received 14 January 1969; accepted 14 February 1969.


This article has been cited by other articles:


Home page
BrainHome page
C. R Trevitt and J. Collinge
A systematic review of prion therapeutics in experimental models
Brain, September 1, 2006; 129(9): 2241 - 2265.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1969 by the Society for General Microbiology.